CHD7 Disorder-Not CHARGE Syndrome-Presenting as Isolated Cochleovestibular Dysfunction

Genes (Basel). 2024 May 19;15(5):643. doi: 10.3390/genes15050643.

Abstract

CHARGE syndrome, characterized by a distinct set of clinical features, has been linked primarily to mutations in the CHD7 gene. Initially defined by specific clinical criteria, including coloboma, heart defects, choanal atresia, delayed growth, and ear anomalies, CHARGE syndrome's diagnostic spectrum has broadened since the identification of CHD7. Variants in this gene exhibit considerable phenotypic variability, leading to the adoption of the term "CHD7 disorder" to encompass a wider range of associated symptoms. Recent research has identified CHD7 variants in individuals with isolated features such as autism spectrum disorder or gonadotropin-releasing hormone deficiency. In this study, we present three cases from two different families exhibiting audiovestibular impairment as the primary manifestation of a CHD7 variant. We discuss the expanding phenotypic variability observed in CHD7-related disorders, highlighting the importance of considering CHD7 in nonsyndromic hearing loss cases, especially when accompanied by inner ear malformations on MRI. Additionally, we underscore the necessity of genetic counseling and comprehensive clinical evaluation for individuals with CHD7 variants to ensure appropriate management of associated health concerns.

Keywords: CHARGE syndrome; CHD7 Genotype–phenotype; cochleovestibular audiometry; nonsyndromic hearing loss.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • CHARGE Syndrome* / diagnosis
  • CHARGE Syndrome* / genetics
  • Child
  • Child, Preschool
  • DNA Helicases* / genetics
  • DNA-Binding Proteins* / genetics
  • Female
  • Humans
  • Male
  • Mutation
  • Pedigree
  • Phenotype

Substances

  • CHD7 protein, human
  • DNA Helicases
  • DNA-Binding Proteins

Grants and funding

This research received no external funding.